Frederick W Miller Selected Research

Myositis (Idiopathic Inflammatory Myopathies)

6/2022	47XXY and 47XXX in Scleroderma and Myositis.
4/2022	Environmental factors associated with juvenile idiopathic inflammatory myopathy clinical and serologic phenotypes.
1/2022	Preliminary validation of muscle ultrasound in juvenile dermatomyositis (JDM).
1/2022	Association of anti-HSC70 autoantibodies with cutaneous ulceration and severe disease in juvenile dermatomyositis.
1/2022	Anti-Cortactin Autoantibodies Are Associated With Key Clinical Features in Adult Myositis But Are Rarely Present in Juvenile Myositis.
12/2021	Idiopathic inflammatory myopathies.
10/2021	Anti-mitochondrial autoantibodies are associated with cardiomyopathy, dysphagia, and features of more severe disease in adult-onset myositis.
3/2021	Accumulation of autophagosome cargo protein p62 is common in idiopathic inflammatory myopathies.
1/2021	Anti-MDA5 autoantibodies associated with juvenile dermatomyositis constitute a distinct phenotype in North America.
1/2020	Neutrophil dysregulation is pathogenic in idiopathic inflammatory myopathies.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Frederick W Miller Research Topics

Disease

57	Myositis (Idiopathic Inflammatory Myopathies) 06/2022 - 07/2002
35	Dermatomyositis (Dermatopolymyositis) 01/2022 - 07/2002
16	Autoimmune Diseases (Autoimmune Disease) 06/2022 - 02/2002
14	Polymyositis 12/2021 - 08/2003
6	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 07/2013
4	Inclusion Body Myositis 12/2021 - 11/2005
4	Connective Tissue Diseases (Connective Tissue Disease) 01/2019 - 11/2006
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 06/2022 - 03/2014
3	Systemic Scleroderma (Systemic Sclerosis) 06/2022 - 09/2003
3	Muscular Diseases (Myopathy) 12/2021 - 11/2006
3	Arthritis (Polyarthritis) 01/2021 - 04/2009
3	Neoplasms (Cancer) 11/2014 - 11/2005
3	Rheumatoid Arthritis 12/2012 - 02/2002
2	Deglutition Disorders (Dysphagia) 01/2022 - 10/2021
2	Rheumatic Diseases (Rheumatism) 01/2022 - 04/2014
2	Arthralgia (Joint Pain) 01/2021 - 07/2013
2	Inflammation (Inflammations) 01/2020 - 01/2015
2	Muscle Weakness 01/2018 - 08/2005
2	Infections 01/2017 - 03/2016
2	Muscular Atrophy (Muscle Atrophy) 12/2013 - 11/2009
2	Exanthema (Rash) 07/2013 - 11/2006
2	Multiple Sclerosis 12/2012 - 02/2002
2	Eosinophilia-Myalgia Syndrome 11/2011 - 10/2009
2	Calcinosis 01/2009 - 12/2008
1	Klinefelter Syndrome (Klinefelter's Syndrome) 06/2022
1	Gastroenteritis 04/2022
1	Hypersensitivity (Allergy) 01/2022
1	Asthma (Bronchial Asthma) 01/2022
1	Ulcer 01/2022
1	COVID-19 01/2022
1	Amyopathic dermatomyositis 12/2021
1	Antisynthetase syndrome 12/2021
1	Cardiomyopathies (Cardiomyopathy) 10/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Lymphadenopathy 01/2021
1	Bites and Stings (Sting) 01/2020
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2018
1	Lung Diseases (Lung Disease) 11/2017
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2017
1	Type 2 Diabetes Mellitus (MODY) 01/2017

Drug/Important Bio-Agent (IBA)

42	AutoantibodiesIBA 04/2022 - 02/2002
8	Mi-2 antibodiesIBA 01/2022 - 07/2002
7	Rituximab (Mabthera)FDA Link 05/2017 - 02/2013
6	AntibodiesIBA 01/2022 - 02/2006
5	Ligases (Synthetase)IBA 02/2022 - 11/2006
5	Creatine Kinase (Creatine Phosphokinase)IBA 01/2022 - 04/2010
4	EnzymesIBA 01/2022 - 10/2002
4	AutoantigensIBA 03/2014 - 08/2009
3	InterferonsIBA 06/2022 - 01/2019
3	VaccinesIBA 01/2022 - 04/2009
3	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2022 - 04/2010
3	Proteins (Proteins, Gene)FDA Link 03/2021 - 11/2006
3	Interferon Type IIBA 10/2020 - 09/2010
3	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2019
3	Prednisone (Sone)FDA LinkGeneric 01/2018 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 01/2017 - 11/2014
3	CytokinesIBA 03/2014 - 12/2008
3	Signal Recognition ParticleIBA 03/2014 - 11/2006
2	Complement System Proteins (Complement)IBA 06/2022 - 01/2016
2	Biological ProductsIBA 01/2022 - 01/2015
2	HLA-DRB1 Chains (HLA DRB1)IBA 01/2021 - 03/2006
2	ORALIT (ORS)IBA 01/2020 - 04/2009
2	Oxidoreductases (Dehydrogenase)IBA 01/2020 - 01/2017
2	Methotrexate (Mexate)FDA LinkGeneric 05/2017 - 01/2017
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 05/2017 - 01/2017
2	beta-cyclodextrin tetradecasulfate (CTDS)IBA 05/2014 - 11/2006
2	SolventsIBA 12/2012 - 02/2002
2	Silicon Dioxide (Silica)FDA LinkGeneric 12/2012 - 02/2002
2	Tryptophan (L-Tryptophan)FDA Link 11/2011 - 10/2009
2	Blood Proteins (Serum Proteins)IBA 07/2011 - 01/2007
2	Peptides (Polypeptides)IBA 12/2006 - 11/2005
2	HLA-A Antigens (HLA-A)IBA 03/2006 - 11/2005
1	ImmunosorbentsIBA 01/2022
1	CortactinIBA 01/2022
1	Prostaglandins AIBA 01/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 10/2021
1	GlucocorticoidsIBA 10/2021
1	EpitopesIBA 01/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021
1	transcriptional intermediary factor 1IBA 01/2021
1	nuclear matrix protein 2IBA 01/2021
1	ProteomeIBA 10/2020
1	MetalsIBA 01/2020
1	Interleukin-8 (Interleukin 8)IBA 01/2020
1	Cell Adhesion Molecule-1IBA 01/2020
1	apolipoprotein A-IV (apolipoprotein AIV)IBA 01/2020
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 01/2020
1	SS-A antibodiesIBA 01/2019
1	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 01/2019
1	Infliximab (Remicade)FDA Link 01/2018
1	5'-Nucleotidase (5' Nucleotidase)IBA 01/2018
1	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 01/2017
1	CarbonIBA 01/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2017

Therapy/Procedure

8	Therapeutics 01/2016 - 03/2003
2	Aftercare (After-Treatment) 03/2016 - 01/2009
1	Self-Help Devices (Assistive Technology) 01/2022
1	Polypharmacy 11/2017